NORTH COAST EMERGENCY MEDICAL SERVICES Policy #5331
POLICIES AND PROCEDURES
Subject: Medical Control
Aspirin
Associated Policies: 6511
I. Indications
Chest pain or other signs and symptoms suggestive of acute myocardial infarction (AMI).
II. Therapeutic Effects
Appears to impede clotting by blocking prostaglandin synthesis, which prevents formation of the platelet - aggregating substance thromboxane.
III. Contraindications
A. Absolute
Known hypersensitivity to aspirin.
B. Relative
None. Benefits of anti-platelet effect strongly outweigh risks of single dose use.
IV. Adverse Effects
A. Hypersensitivity, manifested by anaphylaxis or asthma.
B. Nausea.
C. Vomiting.
D. Gastrointestinal distress.
E. Occult bleeding/minor bleeding.
V. Administration and Dosage
160-325 mg nonenteric-coated (2-4 children’s 80 mg tablets or _-1 325 mg adult tablet), chewed and swallowed.
VI. Special Information
A. Does not increase risk of hemorrhagic stroke.
B. Produces a 23% decrease in AMI mortality, even when used without thrombolytic drugs.
C. Appears to be safe for use during pregnancy.
Approved: Date:
Approved As To Form: Date: